资讯

Weight-loss drugs may be covered by Medicare, Medicaid under experimental program
A move to cover expensive weight-loss drugs for Americans on Medicare and Medicaid may be in the works, but any such program ...
Trump administration to trial Medicare, Medicaid coverage for obesity drugs: WaPO
Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock gain as Trump administration to trial Medicare, Medicaid coverage for ...
Medicare, Medicaid plan to experiment with covering weight loss drugs
The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...
Feds Launch Experiment to Have Medicare Cover GLP-1 Weight Loss Drugs
The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...
US plans Medicare, Medicaid coverage for weight-loss drugs, Washington Post reports
The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington ...
Medicaid, Medicare may cover weight loss drugs under new pilot program: report
Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach for many obese Americans.
US Plans to Test Medicare, Medicaid Coverage for Weight-Loss Drugs, Washington Post Reports
According to the Washington Post, 13 states currently cover the drugs for Medicaid patients, while Medicare prohibits ...
Medicare Update: Trump Admin Launching Pilot Program to Cover Ozempic
Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural phenomenon.
Medicare and Medicaid move toward covering Ozempic and other weight loss drugs
Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...
Devdiscourse2 天
Medicare's Bold Experiment: Weight-Loss Drugs on the Horizon
The Trump administration outlines a plan to cover weight-loss drugs under Medicare and Medicaid, allowing certain state ...
Devdiscourse2 天
Medicare and Medicaid May Expand Coverage for Weight-Loss Drugs
The Trump administration is exploring a five-year pilot program to include weight-loss drugs like Wegovy, Ozempic, Zepbound, ...
A Medicare experiment could change who gets Ozempic
A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.